{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=PO+azithromycin&page=2", "query": { "intervention": "PO azithromycin", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=PO+azithromycin&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-26T02:35:06.610Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04349410", "title": "The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "CoVid 19 Positive" ], "interventions": [ { "name": "Hydroxychloroquine, Azithromycin", "type": "DRUG" }, { "name": "Hydroxychloroquine, Doxycycline", "type": "DRUG" }, { "name": "Hydroxychloroquine, Clindamycin", "type": "DRUG" }, { "name": "Hydroxychloroquine, Clindamycin, Primaquine - low dose.", "type": "DRUG" }, { "name": "Hydroxychloroquine, Clindamycin, Primaquine - high dose.", "type": "DRUG" }, { "name": "Remdesivir", "type": "DRUG" }, { "name": "Tocilizumab", "type": "DRUG" }, { "name": "Methylprednisolone", "type": "DRUG" }, { "name": "Interferon-Alpha2B", "type": "DRUG" }, { "name": "Losartan", "type": "DRUG" }, { "name": "Convalescent Serum", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "The Camelot Foundation", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 1800, "start_date": "2020-04-11", "completion_date": "2020-09-14", "has_results": false, "last_update_posted_date": "2020-11-12", "last_synced_at": "2026-09-26T02:35:06.610Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04349410" }, { "nct_id": "NCT06396078", "title": "Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Preterm Premature Rupture of Membrane", "Pregnancy, High Risk", "Preterm Birth" ], "interventions": [ { "name": "Ceftriaxone 1000 MG", "type": "DRUG" }, { "name": "Clarithromycin 500mg", "type": "DRUG" }, { "name": "Metronidazole 500 mg", "type": "DRUG" }, { "name": "Ampicillin 2 GM Injection", "type": "DRUG" }, { "name": "Amoxicillin 250 MG", "type": "DRUG" }, { "name": "Azithromycin", "type": "DRUG" }, { "name": "Erythromycin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ohio State University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 56, "start_date": "2024-07-18", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2026-01-27", "last_synced_at": "2026-09-26T02:35:06.610Z", "location_count": 2, "location_summary": "Columbus, Ohio • Galveston, Texas", "locations": [ { "city": "Columbus", "state": "Ohio" }, { "city": "Galveston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06396078" }, { "nct_id": "NCT02024555", "title": "Phase II Investigation of Antimycobacterial Therapy on Progressive, Pulmonary Sarcoidosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Sarcoidosis; Antimycobacterial Therapy" ], "interventions": [ { "name": "Levofloxacin", "type": "DRUG" }, { "name": "Ethambutol", "type": "DRUG" }, { "name": "Azithromycin", "type": "DRUG" }, { "name": "Rifampin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Vanderbilt University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 97, "start_date": "2014-03", "completion_date": "2019-04-01", "has_results": true, "last_update_posted_date": "2020-07-09", "last_synced_at": "2026-09-26T02:35:06.610Z", "location_count": 6, "location_summary": "Albany, New York • Cincinnati, Ohio • Cleveland, Ohio + 3 more", "locations": [ { "city": "Albany", "state": "New York" }, { "city": "Cincinnati", "state": "Ohio" }, { "city": "Cleveland", "state": "Ohio" }, { "city": "Columbus", "state": "Ohio" }, { "city": "Charleston", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02024555" }, { "nct_id": "NCT00153634", "title": "Standard vs. Biofilm Susceptibility Testing in Cystic Fibrosis (CF)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cystic Fibrosis", "Chronic Bronchitis" ], "interventions": [ { "name": "IV amikacin", "type": "DRUG" }, { "name": "PO azithromycin", "type": "DRUG" }, { "name": "IV ceftazidime", "type": "DRUG" }, { "name": "PO ciprofloxacin", "type": "DRUG" }, { "name": "IV meropenem", "type": "DRUG" }, { "name": "IV piperacillin-tazobactam", "type": "DRUG" }, { "name": "IV ticarcillin-clavulanate", "type": "DRUG" }, { "name": "IV tobramycin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Seattle Children's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "14 Years", "maximum_age": null, "sex": "ALL", "summary": "14 Years and older" }, "enrollment_count": 75, "start_date": "2004-03", "completion_date": "2007-11", "has_results": false, "last_update_posted_date": "2008-03-13", "last_synced_at": "2026-09-26T02:35:06.610Z", "location_count": 8, "location_summary": "Iowa City, Iowa • St Louis, Missouri • Cincinnati, Ohio + 4 more", "locations": [ { "city": "Iowa City", "state": "Iowa" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Cincinnati", "state": "Ohio" }, { "city": "Columbus", "state": "Ohio" }, { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00153634" }, { "nct_id": "NCT04344457", "title": "Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "COVID-19" ], "interventions": [ { "name": "Hydroxychloroquine", "type": "DRUG" }, { "name": "Indomethacin", "type": "DRUG" }, { "name": "Zithromax Oral Product", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Perseverance Research Center, LLC", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 80, "start_date": "2020-04-16", "completion_date": "2020-09-30", "has_results": false, "last_update_posted_date": "2020-07-01", "last_synced_at": "2026-09-26T02:35:06.610Z", "location_count": 2, "location_summary": "Scottsdale, Arizona • New Orleans, Louisiana", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "New Orleans", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT04344457" }, { "nct_id": "NCT04336332", "title": "Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "SARS-CoV-2", "COVID-19" ], "interventions": [ { "name": "Hydroxychloroquine Sulfate + Azithromycin", "type": "COMBINATION_PRODUCT" }, { "name": "Hydroxychloroquine Sulfate", "type": "DRUG" } ], "intervention_types": [ "COMBINATION_PRODUCT", "DRUG" ], "sponsor": "Rutgers, The State University of New Jersey", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 75, "start_date": "2020-04-01", "completion_date": "2020-10-14", "has_results": true, "last_update_posted_date": "2023-02-28", "last_synced_at": "2026-09-26T02:35:06.610Z", "location_count": 5, "location_summary": "Livingston, New Jersey • New Brunswick, New Jersey • Newark, New Jersey", "locations": [ { "city": "Livingston", "state": "New Jersey" }, { "city": "New Brunswick", "state": "New Jersey" }, { "city": "New Brunswick", "state": "New Jersey" }, { "city": "Newark", "state": "New Jersey" }, { "city": "Newark", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT04336332" }, { "nct_id": "NCT04334382", "title": "Hydroxychloroquine vs. Azithromycin for Outpatients in Utah With COVID-19", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "COVID-19" ], "interventions": [ { "name": "Hydroxychloroquine", "type": "DRUG" }, { "name": "Azithromycin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Intermountain Health Care, Inc.", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": null, "sex": "ALL", "summary": "45 Years and older" }, "enrollment_count": 1550, "start_date": "2020-04-02", "completion_date": "2021-12-31", "has_results": false, "last_update_posted_date": "2020-04-09", "last_synced_at": "2026-09-26T02:35:06.610Z", "location_count": 2, "location_summary": "Murray, Utah • Salt Lake City, Utah", "locations": [ { "city": "Murray", "state": "Utah" }, { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT04334382" }, { "nct_id": "NCT01307462", "title": "Targeted Therapy of Bronchiolitis Obliterans Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Bronchiolitis Obliterans" ], "interventions": [ { "name": "fluticasone propionate", "type": "DRUG" }, { "name": "montelukast sodium", "type": "DRUG" }, { "name": "azithromycin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Stephanie Lee", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "6 Years to 99 Years" }, "enrollment_count": 36, "start_date": "2011-06", "completion_date": "2015-12", "has_results": true, "last_update_posted_date": "2017-10-04", "last_synced_at": "2026-09-26T02:35:06.610Z", "location_count": 11, "location_summary": "Scottsdale, Arizona • Stanford, California • Tampa, Florida + 8 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Stanford", "state": "California" }, { "city": "Tampa", "state": "Florida" }, { "city": "Bethesda", "state": "Maryland" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01307462" }, { "nct_id": "NCT04344444", "title": "Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "COVID-19" ], "interventions": [ { "name": "Hydroxychloroquine", "type": "DRUG" }, { "name": "Azithromycin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "LCMC Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 22, "start_date": "2020-04-13", "completion_date": "2022-01-05", "has_results": false, "last_update_posted_date": "2022-01-21", "last_synced_at": "2026-09-26T02:35:06.610Z", "location_count": 1, "location_summary": "New Orleans, Louisiana", "locations": [ { "city": "New Orleans", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT04344444" }, { "nct_id": "NCT01556334", "title": "Erythromycin Versus Azithromycin in Preterm Premature Rupture of Membranes", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Preterm Premature Ruptured Membranes" ], "interventions": [ { "name": "Azithromycin", "type": "DRUG" }, { "name": "Erythromycin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Indiana University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 0, "start_date": "2010-04", "completion_date": "2012-10", "has_results": false, "last_update_posted_date": "2024-10-15", "last_synced_at": "2026-09-26T02:35:06.610Z", "location_count": 1, "location_summary": "Indianapolis, Indiana", "locations": [ { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT01556334" } ] }